Keith Vrbicky - Concepedia

Author

Keith Vrbicky

Meridian Clinical Research

Also Known As

K Vrbicky, Keith Vrbicky, Keith W. Vrbicky, Kimberly Mueller, Mandy Vowell

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Meridian Clinical Research Moderna Therapeutics (United States)Brigham and Women's Hospital South African Medical Research Council Creighton University

About

Keith Vrbicky is an author at Meridian Clinical Research specializing in medicine, vaccine safety, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	115
2	Endocrinology	1	1	39
3	Immunology	1	1	76
4	Obstetrics	1	1	39
5	Female Reproductive Function	1	1	39

Keith Vrbicky

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, New England Journal of Medicine	2022	638
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants Shabir A. Madhi, Fernando P. Polack, Pedro A. Piedra, New England Journal of Medicine	2020	408
Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility Paul Bradley, Michael Shiekh, Vishaal Mehra, Journal of Psychiatric Research	2017	213
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial Laurence Chu, Keith Vrbicky, David C. Montefiori, Nature Medicine	2022	100
A Bivalent Omicron-containing Booster Vaccine Against Covid-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, VaccinationVaccine SafetyGmt RatioVaccine DevelopmentMedicine	2022	76
Evidence for the involvement of β-endorphin in the human menstrual cycle Keith Vrbicky, John S. Baumstark, Ibert C. Wells, Fertility and Sterility GynecologyMenstrual HealthFemale Reproductive FunctionReproductive HormoneHuman Menstrual Cycle	1982	39
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, Nature Communications	2023	27
Three-month Antibody Persistence of a Bivalent Omicron-containing Booster Vaccine Against COVID-19 Spyros Chalkias, Charles Harper, Keith Vrbicky,	2022	21
Risk of COVID-19 after natural infection or vaccination Anne-Marie Rick, Matthew B. Laurens, Ying Huang, EBioMedicine	2023	13

Page 1